Home
Scholarly Works
A phase II study of sunitinib in recurrent or...
Journal article

A phase II study of sunitinib in recurrent or metastatic endometrial carcinoma: A trial of the Princess Margaret Hospital, The University of Chicago, and California Cancer Phase II Consortia.

Authors

Correa R; Mackay H; Hirte HW; Morgan R; Welch S; Fleming GF; Wang L; Blattler C; Ivy SP; Oza AM

Journal

Journal of Clinical Oncology, Vol. 28, No. 15_suppl, pp. 5038–5038

Publisher

American Society of Clinical Oncology (ASCO)

Publication Date

May 20, 2010

DOI

10.1200/jco.2010.28.15_suppl.5038

ISSN

0732-183X
View published work (Non-McMaster Users)

Contact the Experts team